SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-045973
Filing Date
2020-04-13
Accepted
2020-04-13 16:52:15
Documents
51
Period of Report
2020-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2015274d1_10q.htm 10-Q 292533
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 10896
3 EXHIBIT 32.1 ex32-1.htm EX-32.1 4552
  Complete submission text file 0001104659-20-045973.txt   3080450

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT qbio-20200229.xml EX-101.INS 739746
5 XBRL TAXONOMY EXTENSION SCHEMA qbio-20200229.xsd EX-101.SCH 30846
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20200229_cal.xml EX-101.CAL 26388
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20200229_def.xml EX-101.DEF 116942
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20200229_lab.xml EX-101.LAB 267895
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20200229_pre.xml EX-101.PRE 215113
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 20789178
SIC: 2834 Pharmaceutical Preparations